In 2009, Sequenom Center for Molecular Medicine (SCMM) was expected to launch the SEQureDx prenatal screening tests for Down syndrome and Rhesus D. Subsequent investigation revealed significant flaws in the studies of the test's effectiveness.
•
MaterniT21 PLUS is Sequenom Center for Molecular Medicine's prenatal test for trisomy 21 Down syndrome, trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome).